Abatacept for rheumatoid arthritis

To browse Podcasts by topic, please visit the new Cochrane Summaries site here

A new Cochrane review examines the research into abatacept, one of the newer drugs for rheumatoid arthritis. Chris Mavergames from the German Cochrane Centre spoke with Lara Maxwell, Managing Editor of the Cochrane Musculoskeletal Group, based at the University of Ottawa , in Canada about her findings

Play Now!

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.
Download [mp3]  | Read Review
library
Subscribe To all future Podcasts
Subscribe with iTunes
Updated on: June 20, 2011, 13:52

Copyright © The Cochrane Collaboration
Comments for improvement or correction are welcome.
Email: web@cochrane.org